Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: The Lancet Gastroenterology & Hepatology

Abbreviated Title: The Lancet Gastroenterology & Hepatology

Publisher: Elsevier BV

ISSN (Print): 24681253

Publication date Created: September 2020

Publication date (Print): September 2020

Volume: 5

Issue: 9

Pages: 819-828

Article

DOI: 10.1016/S2468-1253(20)30188-6

PubMed ID: 32553149

SO-VID: b613a5b7-0f49-4533-866f-d11e58a525c7

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.